Physician profile
Brian Scott Kirschner
NPI 1821095449
$1,286.71
in general payments reported to CMS, 2019-2025
22 companies · $281 in 2025
The $281 reported for 2025 was more than what 83% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $121 · 2021: $238 · 2022: $67.46 · 2023: $45.42 · 2024: $182 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $169.84 | 2019-2021 | |
| Sanofi Pasteur INC. | $141.82 | 2019-2025 | |
| Glaxosmithkline, LLC. | $135.37 | 2019-2025 | Bexsero |
| Mirum Pharmaceuticals, INC. | $128.16 | 2024 | Livmarli |
| Genentech USA, INC. | $94.02 | 2025 | Ocrevus Zunovo |
| Takeda Pharmaceuticals U.S.A., INC. | $85.15 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $81.71 | 2019-2023 | Vaxneuvance, Gardasil 9, Rotateq |
| Neos Therapeutics, LP | $74.52 | 2019-2025 | Cotempla Xr-Odt |
| Biofire Diagnostics, LLC | $59.93 | 2019-2021 | |
| Pfizer INC. | $42.04 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $41.22 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $32.85 | 2021 | |
| Sobi, INC | $31.05 | 2019 | |
| Ironshore Pharmaceuticals INC. | $26.68 | 2019 | |
| Cranial Technologies, INC | $24.71 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $24.50 | 2025 | Neffy |
| Kaleo, INC. | $17.19 | 2020 | |
| Biomerieux INC | $15.87 | 2021 | |
| Alk-Abello, INC | $15.54 | 2025 | Neffy |
| Adlon Therapeutics L.P. | $15.17 | 2019 | |
| Shire North American Group INC | $15.15 | 2019 | |
| Lnhc, INC | $14.22 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kirschner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.